# EQT Life Sciences' Biotech Investments: 30 Startups in Its Portfolio (2026) > The 30 Biotech startups EQT Life Sciences has backed, by stage: $2.9B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/eqt-life-sciences-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 9 - [Noema Pharma](https://millionrounds.com/company/noema-pharma) - [ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics) - [Atalanta Therapeutics](https://millionrounds.com/company/atalanta-therapeutics) - [QurAlis](https://millionrounds.com/company/quralis) - [Cardior Pharmaceuticals](https://millionrounds.com/company/cardior-pharmaceuticals) - [XyloCor Therapeutics](https://millionrounds.com/company/xylocor-therapeutics) - [DNA Script](https://millionrounds.com/company/dna-script) - [etherna immunotherapies](https://millionrounds.com/company/etherna-immunotherapies) - [Vico Therapeutics](https://millionrounds.com/company/vico-therapeutics) ## Stage not reported 8 - [Tenpoint Therapeutics](https://millionrounds.com/company/tenpoint-therapeutics) - [Evommune](https://millionrounds.com/company/evommune) - [AviadoBio](https://millionrounds.com/company/aviadobio) - [*M* Minervax](https://millionrounds.com/company/minervax) - [VarmX](https://millionrounds.com/company/varmx) - [Visus Therapeutics](https://millionrounds.com/company/visus-therapeutics) - [Xilis](https://millionrounds.com/company/xilis) - [Egle Therapeutics](https://millionrounds.com/company/egle-therapeutics) ## Series A 8 - [Arvelle Therapeutics](https://millionrounds.com/company/arvelle-therapeutics) - [VectorY](https://millionrounds.com/company/vectory) - [AstronauTx](https://millionrounds.com/company/astronautx) - [*MT* Mosanna Therapeutics](https://millionrounds.com/company/mosanna-therapeutics) - [Shinobi Therapeutics](https://millionrounds.com/company/shinobi-therapeutics) - [FoRx Therapeutics](https://millionrounds.com/company/forx-therapeutics) - [Ariceum Therapeutics](https://millionrounds.com/company/ariceum-therapeutics) - [Luxendo](https://millionrounds.com/company/luxendo) ## Series C and later 5 - [Tubulis](https://millionrounds.com/company/tubulis) - [Nouscom](https://millionrounds.com/company/nouscom) - [*AP* Amolyt Pharma](https://millionrounds.com/company/amolyt-pharma) - [AgomAB Therapeutics](https://millionrounds.com/company/agomab-therapeutics) - [Phagenesis](https://millionrounds.com/company/phagenesis) ## Segment by segment ### Series B 9 startups · $707M raised - [**Noema Pharma**](https://millionrounds.com/company/noema-pharma) Noema Pharma is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 by George Garibaldi and Luigi Costa. Switzerland $147M - [**ImCheck Therapeutics**](https://millionrounds.com/company/imcheck-therapeutics) ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules. France $97M - [**Atalanta Therapeutics**](https://millionrounds.com/company/atalanta-therapeutics) Atalanta Therapeutics is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies for ce United States $97M - [**QurAlis**](https://millionrounds.com/company/quralis) QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD. United States $94M - [**Cardior Pharmaceuticals**](https://millionrounds.com/company/cardior-pharmaceuticals) Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease. Germany $92M - [**XyloCor Therapeutics**](https://millionrounds.com/company/xylocor-therapeutics) XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. United States $68M - [**DNA Script**](https://millionrounds.com/company/dna-script) DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health. France $62M - [**etherna immunotherapies**](https://millionrounds.com/company/etherna-immunotherapies) eTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system. Belgium $39M ### Stage not reported 8 startups · $504M raised - [**Tenpoint Therapeutics**](https://millionrounds.com/company/tenpoint-therapeutics) Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics. United Kingdom $150M - [**Evommune**](https://millionrounds.com/company/evommune) Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms. United States $125M - [**AviadoBio**](https://millionrounds.com/company/aviadobio) AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene t United Kingdom $93M - [*M* **Minervax**](https://millionrounds.com/company/minervax) Denmark $62M - [**VarmX**](https://millionrounds.com/company/varmx) VarmX B.V. Netherlands $25M - [**Visus Therapeutics**](https://millionrounds.com/company/visus-therapeutics) Visus Therapeutics is a clinical-stage company developing innovative medicines. United States $20M - [**Xilis**](https://millionrounds.com/company/xilis) Xilis is an oncology and precision health company that provides technologies to diagnoses cancer. United States $19M - [**Egle Therapeutics**](https://millionrounds.com/company/egle-therapeutics) Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases. France $9.4M ### Series A 8 startups · $723M raised - [**Arvelle Therapeutics**](https://millionrounds.com/company/arvelle-therapeutics) Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution. Switzerland $223M - [**VectorY**](https://millionrounds.com/company/vectory) VectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020. Netherlands $138M - [**AstronauTx**](https://millionrounds.com/company/astronautx) AstronauTx Ltd. United Kingdom $124M - [*MT* **Mosanna Therapeutics**](https://millionrounds.com/company/mosanna-therapeutics) Switzerland $80M - [**Shinobi Therapeutics**](https://millionrounds.com/company/shinobi-therapeutics) Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment. United States $68M - [**FoRx Therapeutics**](https://millionrounds.com/company/forx-therapeutics) FoRx Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland. Switzerland $50M - [**Ariceum Therapeutics**](https://millionrounds.com/company/ariceum-therapeutics) Ariceum Therapeutics is a private, clinical-stage radiopharmaceutical company based in Berlin, Germany. Germany $25M - [**Luxendo**](https://millionrounds.com/company/luxendo) Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments. Germany $15M ### Series C and later 5 startups · $953M raised - [**Tubulis**](https://millionrounds.com/company/tubulis) Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment. Germany $401M - [**Nouscom**](https://millionrounds.com/company/nouscom) Nouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities i Switzerland $191M - [*AP* **Amolyt Pharma**](https://millionrounds.com/company/amolyt-pharma) Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. France $139M - [**AgomAB Therapeutics**](https://millionrounds.com/company/agomab-therapeutics) AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. Belgium $112M - [**Phagenesis**](https://millionrounds.com/company/phagenesis) Phagenesis Ltd. United Kingdom $110M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names EQT Life Sciences as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with EQT Life Sciences** 33 co-investors](https://millionrounds.com/portfolio-maps/eqt-life-sciences-co-investors)[Sector portfolio **True Ventures' AI portfolio** 50 startups · $1.9B](https://millionrounds.com/portfolio-maps/true-ventures-2-ai-portfolio)[Sector portfolio **EIT InnoEnergy's Energy portfolio** 20 startups · $289M](https://millionrounds.com/portfolio-maps/innoenergy-energy-portfolio)[Sector portfolio **Maven 11 Capital's Web3 & Crypto portfolio** 19 startups · $161M](https://millionrounds.com/portfolio-maps/maven-11-web3-crypto-portfolio)[Sector portfolio **Prosus Ventures' AI portfolio** 17 startups · $374M](https://millionrounds.com/portfolio-maps/prosus-ventures-ai-portfolio)[Sector portfolio **True Ventures' Fintech portfolio** 13 startups · $423M](https://millionrounds.com/portfolio-maps/true-ventures-2-fintech-portfolio) ## Raising from investors like EQT Life Sciences? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)